What is the recommended medical management for Parkinsonism?

Medical Management of Parkinsonism

Levodopa is the most effective medication for treating motor symptoms of Parkinson's disease and should be used as first-line therapy when functional disability develops, particularly in patients over 75 years or those requiring immediate symptom control 1, 2, 3.

Initial Treatment Strategy

The choice of initial therapy depends on patient age, symptom severity, and functional status:

For Younger Patients (<60-75 years) with Mild Symptoms

• Start with MAO-B inhibitors (selegiline, rasagiline) or non-ergot dopamine agonists to delay levodopa-related motor complications 2, 3, 4
• These agents are clinically useful for monotherapy in early disease and have lower risk of dyskinesia development
• Consider this approach even before significant functional deficit develops 4

For Older Patients (>75 years) or Those with Functional Disability

• Initiate oral levodopa preparations immediately 2, 4
• Levodopa provides superior motor symptom control compared to all other medications
• There is no reason to postpone symptomatic treatment when disability is present 5

For Tremor-Dominant Presentation

• Anticholinergics, beta-blockers, or dopamine agonists may be considered first-line 2
• However, tremor shows inconsistent response to oral medications 6

Managing Motor Fluctuations and Complications

When patients develop "off periods" (worsening symptoms when medication wears off):

Add adjunctive therapy rather than simply increasing levodopa dose:

• Non-ergot dopamine agonists (clinically useful) 3
• COMT inhibitors (entacapone, opicapone - clinically useful) 3
• MAO-B inhibitors (rasagiline - clinically useful) 3
• Safinamide or zonisamide (clinically useful) 3

Managing Dyskinesia

For troublesome dyskinesia:

• Amantadine is clinically useful and should be first-line pharmacologic treatment 3
• Clozapine is also clinically useful but requires monitoring 3
• Consider advanced therapies (see below) for medication-resistant cases

Advanced Therapies for Complex Motor Symptoms

When patients experience medication-resistant tremor, severe off periods, or dyskinesias despite optimal oral therapy, consider:

1. Deep Brain Stimulation (DBS) - STN or GPi targets

   • Clinically useful for motor fluctuations and dyskinesia 3
   • Can be considered even in early disease (patients with early fluctuations who meet criteria) as it improves motor symptoms and quality of life better than medical treatment alone 6
   • STN-DBS is preferred for younger patients as it allows long-term adaptation (>15 years established efficacy) 6

2. Levodopa-Carbidopa Intestinal Gel (LCIG)

   • Clinically useful for motor fluctuations 3
   • Provides continuous dopaminergic stimulation, reducing pulsatility

3. Continuous Apomorphine Infusion (CAI)

   • Effective for motor fluctuations 6

Managing Non-Motor Symptoms

Impulse Control Disorders

Reduce or withdraw dopamine agonists - this is the primary management strategy 2

• Both LCIG and CAI may improve ICDs by reducing pulsatile therapy 6
• Severe psychiatric disorders are contraindications for invasive treatments 6

Psychosis and Hallucinations

First-line: Reduce dopaminergic medication 6

• Add clozapine (most effective, requires monitoring) or quetiapine 6, 2
• Paradoxically, dopamine-reducing interventions like DBS or CAI may improve hallucinations in selected cases with L-dopa-dependent psychosis 6

Cognitive Impairment

• Cholinesterase inhibitors (rivastigmine) may improve dementia symptoms 2
• Rivastigmine is possibly useful as adjunct therapy for motor symptoms in optimized PD 3

Depression

• Antidepressants and pramipexole may improve depression 2

Non-Pharmacological Management

Exercise and physical therapy are clinically useful and should be incorporated at all disease stages 3

• Exercise-based movement strategy training and formalized patterned exercises are possibly useful 3
• Multidisciplinary team approach should start at diagnosis 5

Critical Pitfalls to Avoid

1. Never delay levodopa when functional disability exists - concerns about motor complications should not prevent appropriate symptom control 5
2. Maintain strict medication timing in hospitalized patients - medication errors are associated with longer stays, motor deterioration, and increased mortality 7
3. Avoid dopamine-blocking medications (typical antipsychotics, metoclopramide) that can worsen parkinsonism 7
4. Screen for impulse control disorders regularly when using dopamine agonists 2
5. Perform cognitive assessment before considering DBS - visual hallucinations predict cognitive decline after DBS 6

Disease Modification

Currently, no available therapies alter the underlying neurodegenerative process 5, 1, 3. All treatment remains symptomatic, focused on improving motor and non-motor symptoms to optimize quality of life.